Equities

JZJ Chain Drugstore Corp

605266:SHH

JZJ Chain Drugstore Corp

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (CNY)26.50
  • Today's Change-1.50 / -5.36%
  • Shares traded10.45m
  • 1 Year change-45.69%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments425936726
Total Receivables, Net599645362
Total Inventory2,3742,1661,121
Prepaid expenses5713131
Other current assets, total48362257
Total current assets3,9383,9392,497
Property, plant & equipment, net2,6872,6441,901
Goodwill, net2,4032,243415
Intangibles, net929045
Long term investments47189.80
Note receivable - long term------
Other long term assets116.18--
Total assets9,9499,6445,214
LIABILITIES
Accounts payable1,7541,9831,024
Accrued expenses20222295
Notes payable/short-term debt1,7521,021741
Current portion long-term debt/capital leases573578384
Other current liabilities, total578421177
Total current liabilities4,8604,2252,421
Total long term debt1,9502,155868
Total debt4,2753,7551,993
Deferred income tax28227519
Minority interest(17)(17)(17)
Other liabilities, total1242013
Total liabilities7,0887,0603,304
SHAREHOLDERS EQUITY
Common stock1299970
Additional paid-in capital1,3611,3911,009
Retained earnings (accumulated deficit)1,3791,109857
Treasury stock - common(7.15)(15)(26)
Unrealized gain (loss)------
Other equity, total------
Total equity2,8612,5851,910
Total liabilities & shareholders' equity9,9499,6445,214
Total common shares outstanding154154140
Treasury shares - common primary issue0.350.731.27
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.